Buy One Get One free -Llimited Time Offer X
Insuman Comb 50 Cartridge (3 ml Each) is a prescription medicine that is available as a Injection. It is primarily used for the treatment of Diabetes.
Medical history of the patient along with age and gender determines the dosage of Insuman Comb 50 Cartridge (3 ml Each). Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Insuman Comb 50 Cartridge (3 ml Each) also has some side effects, the most common being Headache, Dizziness, Drowsiness. Usually, these side effects of Insuman Comb 50 Cartridge (3 ml Each) go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Insuman Comb 50 Cartridge (3 ml Each)'s effect during pregnancy is Safe and Safe while nursing. In addition, Insuman Comb 50 Cartridge (3 ml Each)'s effects on the liver, heart and kidney are discussed below in the Insuman Comb 50 Cartridge (3 ml Each) related warnings section.
Insuman Comb 50 Cartridge (3 ml Each) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Insuman Comb 50 Cartridge (3 ml Each) in conditions like Liver Disease.
Additionally, Insuman Comb 50 Cartridge (3 ml Each) may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Insuman Comb 50 Cartridge (3 ml Each) is not safe while driving, and is is not addictive in nature.
Insuman Comb 50 Cartridge (3 ml Each) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Insuman Comb 50 Cartridge (3 ml Each) safe for pregnant women?
Pregnant women can take Insuman Comb safely.
Is the use of Insuman Comb 50 Cartridge (3 ml Each) safe during breastfeeding?
Insuman Comb does not show any side effects in breastfeeding women.
What is the effect of Insuman Comb 50 Cartridge (3 ml Each) on the Kidneys?
Very few cases of side effects of Insuman Comb on kidney have been reported.
What is the effect of Insuman Comb 50 Cartridge (3 ml Each) on the Liver?
Side effects of Insuman Comb rarely affect the liver.
What is the effect of Insuman Comb 50 Cartridge (3 ml Each) on the Heart?
Insuman Comb is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Insuman Comb 50 Cartridge (3 ml Each) unless your doctor advises you to do so -
Is this Insuman Comb 50 Cartridge (3 ml Each) habit forming or addictive?
Insuman Comb 50 Cartridge (3 ml Each) does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Insuman Comb 50 Cartridge (3 ml Each) you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Insuman Comb 50 Cartridge (3 ml Each) only on doctor's advice.
Is it able to treat mental disorders?
No, Insuman Comb 50 Cartridge (3 ml Each) is not used to treat mental disorders.
Interaction between Food and Insuman Comb 50 Cartridge (3 ml Each)
There isn't any research available on the side effects of taking Insuman Comb 50 Cartridge (3 ml Each) with food.
Interaction between Alcohol and Insuman Comb 50 Cartridge (3 ml Each)
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Insuman Comb 50 Cartridge (3 ml Each).
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; NovoLog (insulin aspart)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Fiasp® (insulin aspart)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 689-690
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Novolog® Mix 70/30 (insulin aspart protamine and insulin aspart)
Highlights of Prescribing Information [Internet]: NovoLog (insulin aspart injection). Initial U.S. Approval: 2000